- Home
- Publications
- Publication Search
- Publication Details
Title
GATA2 promotes glioma progression through EGFR/ERK/Elk-1 pathway
Authors
Keywords
GATA2, Glioma, Glioblastoma, EGFR, ERK
Journal
MEDICAL ONCOLOGY
Volume 32, Issue 4, Pages -
Publisher
Springer Nature
Online
2015-02-23
DOI
10.1007/s12032-015-0522-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GATA2 as a potential metastasis-driving gene in prostate cancer
- (2015) Yan Ting Chiang et al. Oncotarget
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation
- (2014) Takashi Moriguchi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Medical therapy of gliomas
- (2014) Manmeet S. Ahluwalia et al. JOURNAL OF NEURO-ONCOLOGY
- Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes
- (2014) M. Labussiere et al. NEUROLOGY
- Glioma Grade Is Associated with the Accumulation and Activity of Cells Bearing M2 Monocyte Markers
- (2013) M. Prosniak et al. CLINICAL CANCER RESEARCH
- The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
- (2012) Madhu S. Kumar et al. CELL
- Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
- (2012) T. E. Taylor et al. CURRENT CANCER DRUG TARGETS
- Combinatorial regulation of tissue specification by GATA and FOG factors
- (2012) T. M. Chlon et al. DEVELOPMENT
- Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
- (2012) Nadzeya Goncharenko-Khaider et al. Molecular Cancer
- Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies
- (2012) E. H. Bresnick et al. NUCLEIC ACIDS RESEARCH
- Differential Regulation of Transcription Factors by Location-Specific EGF Receptor Signaling via a Spatio-Temporal Interplay of ERK Activation
- (2012) Peng Wu et al. PLoS One
- CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target
- (2011) Mizuhiko Terasaki et al. Brain Tumor Pathology
- The role of the GATA2 transcription factor in normal and malignant hematopoiesis
- (2011) Carmen Vicente et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer
- (2011) Yu Wang et al. HUMAN MOLECULAR GENETICS
- Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells
- (2011) Melike Mut et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Imaging of human mesenchymal stromal cells: homing to human brain tumors
- (2011) Lata G. Menon et al. JOURNAL OF NEURO-ONCOLOGY
- Phase I and Pharmacokinetic Studies of Erlotinib Administered Concurrently with Radiotherapy for Children, Adolescents, and Young Adults with High-Grade Glioma
- (2009) A. Broniscer et al. CLINICAL CANCER RESEARCH
- Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy
- (2009) R. K. Kancha et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation